Certara, Inc. (CERT)

Current Report Filed: 2026-04-22

Certara is divesting its global medical writing and regulatory services business to Veristat for $100 million upfront cash plus up to $35 million in contingent earn-out payments, representing a strategic portfolio optimization to focus on core operations.
The transaction structure includes $15 million held in escrow pending satisfaction of closing conditions, providing some downside protection while the earn-out component ties future value realization to post-closing business performance over a specified period.
The deal is subject to customary closing conditions including material adverse effect clauses and completion of internal reorganization steps, with transition services to be provided post-closing, indicating an orderly separation process.

Insider Trading Filed: 2026-04-03

Leif E. Pedersen, the President and Chief Commercial Officer of Certara, Inc. (CERT), has been actively trading the company's stock. He acquired 14,510 shares and exercised 33,167 restricted stock units (RSUs) on April 1, 2026.
The insider transactions appear to be part of Pedersen's ongoing compensation and incentive plan, as the RSUs were granted in previous years and have been vesting over time.
Pedersen has maintained a significant direct ownership stake in Certara, with 110,045 shares beneficially owned after the reported transactions. This suggests continued alignment between Pedersen's interests and those of Certara's shareholders.

Insider Trading Filed: 2026-04-03

Rona Anhalt, the Chief Human Resources Officer of Certara, Inc. (CERT), exercised 9,764 restricted stock units (RSUs) and sold 3,062 shares to cover tax withholding, indicating ongoing insider ownership and confidence in the company.
The vesting and settlement of the RSUs is part of a multi-year incentive plan, suggesting the company is managing executive compensation and aligning it with long-term shareholder interests.
The reported transaction date of April 1, 2026, and the scheduled future vesting dates of April 2027 and April 2028 provide insight into the company's equity compensation program and the officer's expected future share ownership.

Insider Trading Filed: 2026-04-03

Insider Robert Aspbury acquired a significant number of Certara, Inc. (CERT) shares through vesting of restricted stock units and performance stock units, indicating continued confidence in the company's prospects.
Aspbury sold a portion of the shares to cover tax withholdings, a common practice, but still maintains a substantial direct ownership stake in Certara.
The transaction details show a multi-year vesting schedule for Aspbury's equity awards, suggesting long-term alignment between the executive and shareholders.

Insider Trading Filed: 2026-04-03

John E. Gallagher, the Chief Financial Officer of Certara, Inc., exercised a total of 50,605 restricted stock units and performance stock units on April 1, 2026, acquiring a substantial number of Certara shares.
Gallagher sold 27,108 shares to cover tax withholding obligations, indicating that he is retaining a significant portion of the acquired shares.
The reported transactions suggest Gallagher's continued confidence in Certara's long-term prospects and alignment with shareholder interests through his equity holdings.

Insider Trading Filed: 2026-04-03

The reporting person, Daniel Corcoran, exercised 10,849 restricted stock units (RSUs) and sold 5,751 shares to cover tax withholding obligations, indicating potential insider activity and portfolio rebalancing.
The remaining 21,698 RSUs will continue vesting in equal parts over the next two years, suggesting the reporting person maintains a long-term stake in the company.
The transaction price of $5.70 per share is close to the current market price, indicating the sale was likely for tax purposes rather than a bearish signal.

Insider Trading Filed: 2026-04-03

The reporting person, Adrian McKemey, who is the President of Drug Development Solutions at Certara, Inc., exercised 10,849 restricted stock units (RSUs) on April 1, 2026, acquiring an equal number of common shares.
McKemey also sold 2,642 shares to cover tax withholding obligations, leaving him with a direct ownership of 8,207 shares.
The remaining two-thirds of the RSUs will vest and settle in equal parts on April 1, 2027 and April 1, 2028, indicating a continued long-term equity incentive alignment with the company.

Current Report Filed: 2026-03-31

Cynthia Collins, a director and member of the Audit Committee, has announced her resignation from the Certara, Inc. Board of Directors effective May 14, 2026.
The resignation does not appear to be due to any disagreement with the company's operations, policies or practices, according to the filing.
The departure of a director, especially one serving on a key committee like Audit, could signal changes in Certara's leadership or governance structure.

Insider Trading Filed: 2026-03-02

Arjun Bedi, a director of Certara, Inc. (CERT), was granted 5,547 restricted stock units (RSUs) on February 27, 2026 under the company's 2020 Incentive Plan. The RSUs vest on the earlier of the one-year anniversary of the grant date or the date of the company's next annual meeting.
This RSU grant indicates that Bedi, a director, continues to have a vested interest in the company's long-term success and is being compensated through equity-based incentives.
The timing of the RSU grant, shortly before the filing date, suggests the company is proactively managing its equity compensation plan and aligning directors' incentives with shareholders' interests.

Current Report Filed: 2026-02-26

Certara, Inc. announced its financial results for the fourth quarter of 2025, indicating the company's continued growth and operational performance.
The press release highlights the company's revenue and profitability metrics, which appear to be in line with or exceeding investor expectations.
Certara's management team and operations seem stable, with no significant leadership changes or other material events reported in the 8-K filing.

Annual Report Filed: 2026-02-26

Certara, Inc. experienced a 20-month, 24-day period in 2025, indicating potential changes in its financial reporting or operations.
The company's revenue target and its Vyasa Analytics LLC subsidiary suggest potential growth initiatives or acquisitions.
The filing discloses details on Certara's use of interest rate swaps, which could provide insight into its debt and hedging strategies.

Important Information